A detailed history of Dupont Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Dupont Capital Management Corp holds 109,575 shares of ABT stock, worth $12.6 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
109,575
Previous 109,575 -0.0%
Holding current value
$12.6 Million
Previous $11.4 Million 9.72%
% of portfolio
1.06%
Previous 1.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $645,679 - $720,740
-6,410 Reduced 5.53%
109,575 $11.4 Million
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $859,732 - $949,536
-7,850 Reduced 6.34%
115,985 $13.2 Million
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $290,501 - $355,598
-3,221 Reduced 2.54%
123,835 $13.6 Million
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $7.89 Million - $9.47 Million
82,579 Added 185.67%
127,056 $12.3 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $75,181 - $83,768
-746 Reduced 1.65%
44,477 $4.85 Million
Q1 2023

Apr 28, 2023

BUY
$96.86 - $114.01 $915,617 - $1.08 Million
9,453 Added 26.43%
45,223 $4.58 Million
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $643,556 - $754,990
-6,770 Reduced 15.91%
35,770 $0
Q3 2022

Oct 31, 2022

SELL
$96.76 - $112.03 $3.45 Million - $3.99 Million
-35,615 Reduced 45.57%
42,540 $4.12 Million
Q2 2022

Jul 26, 2022

SELL
$102.07 - $123.37 $702,649 - $849,279
-6,884 Reduced 8.1%
78,155 $8.49 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $31,469 - $38,375
276 Added 0.33%
85,039 $10.1 Million
Q4 2021

Jan 31, 2022

SELL
$115.53 - $141.46 $3.42 Million - $4.19 Million
-29,592 Reduced 25.88%
84,763 $11.9 Million
Q3 2021

Nov 03, 2021

BUY
$116.66 - $129.06 $756,306 - $836,695
6,483 Added 6.01%
114,355 $13.5 Million
Q2 2021

Jul 30, 2021

SELL
$105.79 - $124.53 $2.85 Million - $3.36 Million
-26,965 Reduced 20.0%
107,872 $12.5 Million
Q1 2021

Apr 29, 2021

SELL
$108.84 - $128.23 $3.28 Million - $3.86 Million
-30,138 Reduced 18.27%
134,837 $16.2 Million
Q4 2020

Jan 28, 2021

SELL
$105.0 - $114.42 $2.38 Million - $2.6 Million
-22,696 Reduced 12.09%
164,975 $18.1 Million
Q3 2020

Oct 29, 2020

SELL
$91.64 - $111.29 $335,219 - $407,098
-3,658 Reduced 1.91%
187,671 $20.4 Million
Q2 2020

Jul 24, 2020

BUY
$76.57 - $98.0 $5.56 Million - $7.11 Million
72,561 Added 61.09%
191,329 $17.5 Million
Q1 2020

Apr 29, 2020

BUY
$62.82 - $91.86 $2.68 Million - $3.91 Million
42,590 Added 55.91%
118,768 $9.37 Million
Q4 2019

Jan 27, 2020

SELL
$78.51 - $87.4 $3.13 Million - $3.49 Million
-39,903 Reduced 34.38%
76,178 $6.62 Million
Q3 2019

Oct 28, 2019

SELL
$81.84 - $88.74 $4.9 Million - $5.31 Million
-59,888 Reduced 34.03%
116,081 $9.71 Million
Q2 2019

Jul 30, 2019

BUY
$72.88 - $85.0 $850,290 - $991,695
11,667 Added 7.1%
175,969 $14.8 Million
Q1 2019

Apr 30, 2019

SELL
$66.22 - $80.06 $6.06 Million - $7.33 Million
-91,518 Reduced 35.77%
164,302 $13.1 Million
Q4 2018

Feb 01, 2019

SELL
$65.56 - $74.27 $1.05 Million - $1.19 Million
-16,048 Reduced 5.9%
255,820 $18.5 Million
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $6.3 Million - $7.6 Million
-103,577 Reduced 27.59%
271,868 $19.9 Million
Q2 2018

Jul 30, 2018

BUY
$57.57 - $63.54 $59,987 - $66,208
1,042 Added 0.28%
375,445 $22.9 Million
Q1 2018

May 02, 2018

BUY
$56.27 - $63.62 $2.31 Million - $2.61 Million
41,015 Added 12.3%
374,403 $22.4 Million
Q4 2017

Jan 31, 2018

BUY
$53.68 - $57.47 $7.62 Million - $8.16 Million
141,973 Added 74.17%
333,388 $19 Million
Q3 2017

Oct 31, 2017

BUY
$48.06 - $53.64 $9.2 Million - $10.3 Million
191,415
191,415 $10.2 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.